Evidence map›Paper›PMID 21656096›Full record

ReviewDer Urologe. Ausg. A2011

[Vesicoureteral reflux: diagnostics and therapy].

W H Rösch, V Geyer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

W H RöschKlinik für Kinderurologie in Kooperation mit dem Lehrstuhl für Urologie, Universität Regensburg, Klinik St. Hedwig, Steinmetzstr. 1-3, 93049 Regensburg, Deutschland. kinderurologie@barmherzige-regensburg.de
V Geyer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current management of vesicoureteral reflux (VUR) remains controversial. Recent well thought-out randomized studies on VUR in children have led to a debate on diagnostic and therapeutic algorithms. Individual parameters, such as age, gender, clinical course, renal function and scars, dysfunctional elimination syndrome and last but not least the compliance of the parents have gained in importance. Regarding recent data this article gives a summary of diagnostic steps and therapeutic management of VUR.

Indexed as

AlgorithmsAnti-Bacterial AgentsChildChild, PreschoolCross-Sectional StudiesCystoscopyDextransDiagnosis, DifferentialFemaleGenetic Predisposition to DiseaseHumansHyaluronic AcidInfantInfant, NewbornLong-Term CareMaleAnti-Bacterial AgentsdefluxDextransHyaluronic Acid

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.